A Prospective Open-Label Study for Treatment of Infraorbital Hollows Using a Volumizing Hyaluronic Acid Filler

 

 Buy Article Permissions and Reprints

Abstract

This study aimed to prospectively evaluate the effectiveness, patient satisfaction, and early adverse events of using the hyaluronic acid filler VYC-20L for the treatment of infraorbital hollowing. A total of 21 participants underwent injection of VYC-20L. FACE-Q satisfaction surveys before and after treatment along with early adverse events surveys were conducted. Pre- and posttreatment photos were graded, and the Allergan Infraorbital Hollows Scale was used to assess the difference in infraorbital hollowing. The results showed infraorbital hollowing improvement with VYC-20L was significant (p < 0.001). FACE-Q Satisfaction with Eyes scores on average were 27 points higher after treatment (p < 0.001). The mean FACE-Q Satisfaction with Decision score was 74.1%. The most common short-term adverse symptoms were tenderness (67%), swelling (62%), and bruising (52%). This study concludes that VYC-20L is an effective nonsurgical treatment option for infraorbital hollowing with high patient satisfaction.

Publication History

Accepted Manuscript online:
30 May 2023

Article published online:
12 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Sharad J. Dermal fillers for treatment of tear trough deformity: a review of anatomy, treatment techniques and their outcomes. J Cutan Aesthet Surg 2012; 5 (04) 229-238
  CrossrefPubMedGoogle Scholar
• 2 Bravo BSF, Rocha CR, Bastos JT, Silva PM. Comprehensive treatment of periorbital region with hyaluronic acid. J Clin Aesthet Dermatol 2015; 8 (06) 30-35
  PubMedGoogle Scholar
• 3 Haddock NT, Saadeh PB, Boutros S, Thorne CH. The tear trough and lid/cheek junction: anatomy and implications for surgical correction. Plast Reconstr Surg 2009; 123 (04) 1332-1340
  CrossrefPubMedGoogle Scholar
• 4 Donofrio L, Carruthers J, Hardas B. et al. Development and validation of a photonumeric scale for evaluation of infraorbital hollows. Dermatol Surg 2016; 42 (Suppl 1, Suppl 1): S251-S258
  CrossrefPubMedGoogle Scholar
• 5 Finn JC, Cox S. Fillers in the periorbital complex. Facial Plast Surg Clin North Am 2007; 15 (01) 123-132 , viii
  CrossrefPubMedGoogle Scholar
• 6 American Society of Plastic Surgeons. 2020 National Plastic Surgery Statistics. Updated 2021. Accessed June 28, 2021 at: https://www.plasticsurgery.org/documents/News/Statistics/2020/plastic-surgery-statistics-report-2020.pdf
  PubMed
• 7 Glaser DA, Kenkel JM, Paradkar-Mitragotri D, Murphy DK, Romagnano L, Drinkwater A. Duration of effect by injection volume and facial subregion for a volumizing hyaluronic acid filler in treating midface volume deficit. Dermatol Surg 2015; 41 (08) 942-949
  CrossrefPubMedGoogle Scholar
• 8 Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg 2006; 22 (05) 335-341 , discussion 341–343
  CrossrefPubMedGoogle Scholar
• 9 Steinsapir KD, Steinsapir SMG. Deep-fill hyaluronic acid for the temporary treatment of the naso-jugal groove: a report of 303 consecutive treatments. Ophthal Plast Reconstr Surg 2006; 22 (05) 344-348
  CrossrefPubMedGoogle Scholar
• 10 Huber-Vorländer J, Kürten M. Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: a case series. Clin Cosmet Investig Dermatol 2015; 8: 307-312
  CrossrefPubMedGoogle Scholar
• 11 Hall MB, Roy S, Buckingham ED. Novel use of a volumizing hyaluronic acid filler for treatment of infraorbital hollows. JAMA Facial Plast Surg 2018; 20 (05) 367-372
  CrossrefPubMedGoogle Scholar
• 12 Klassen AF, Cano SJ, Schwitzer JA, Scott AM, Pusic AL. FACE-Q scales for health-related quality of life, early life impact, satisfaction with outcomes, and decision to have treatment: development and validation. Plast Reconstr Surg 2015; 135 (02) 375-386
  CrossrefPubMedGoogle Scholar
• 13 Few J, Cox SE, Paradkar-Mitragotri D, Murphy DK. A multicenter, single-blind randomized, controlled study of a volumizing hyaluronic acid filler for midface volume deficit: patient-reported outcomes at 2 years. Aesthet Surg J 2015; 35 (05) 589-599
  CrossrefPubMedGoogle Scholar
• 14 Jones D, Murphy DK. Volumizing hyaluronic acid filler for midface volume deficit: 2-year results from a pivotal single-blind randomized controlled study. Dermatol Surg 2013; 39 (11) 1602-1612
  CrossrefPubMedGoogle Scholar
• 15 U.S. Food and Drug Administration. Juvéderm ^® voluma™ xc – p110033/s047. Updated 2021. Accessed June 28, 2021 at: https://www.fda.gov/medical-devices/recently-approved-devices/juvedermr-volumatm-xc-p110033s047
  PubMed
• 16 Callan P, Goodman GJ, Carlisle I. et al. Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol 2013; 6: 81-89
  CrossrefPubMedGoogle Scholar
• 17 Barone M, Cogliandro A, La Monaca G, Tambone V, Persichetti P. Cognitive investigation study of patients admitted for cosmetic surgery: information, expectations, and consent for treatment. Arch Plast Surg 2015; 42 (01) 46-51
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 Diwan Z, Trikha S, Etemad-Shahidi S, Alli Z, Rennie C, Penny A. A prospective study on safety, complications and satisfaction analysis for tear trough rejuvenation using hyaluronic acid dermal fillers. Plast Reconstr Surg Glob Open 2020; 8 (04) e2753
  CrossrefPubMedGoogle Scholar
• 19 Berguiga M, Galatoire O. Tear trough rejuvenation: a safety evaluation of the treatment by a semi-cross-linked hyaluronic acid filler. Orbit 2017; 36 (01) 22-26
  CrossrefPubMedGoogle Scholar